Belgium is Europe’s biotech leader with its 23% of the total market value of all public European biotech companies.

Walloon Region is a world benchmark in the field of biotechnology. Our region is particularly recognised for and specialised in in-vitro and in-vivo diagnostics, cell therapy, immunology, biopharmacy, radiopharmaceutical applications and innovative medical equipment.

  • 140 companies including biotech, medtech, CRO, CMO, distribution
  • 400 research units
  • 11,000 researchers
  • 5 universities (UCLouvain, ULB, ULiège, UMons, UNamur)
  • Numerous prestigious technology institutes and partners is the Walloon reference accelerator in the field of health biotechnology and medical technologies active in Europe. Its main partners aim, through a Discover-Build-Measure-Learn methodology, to define a strong strategy for the biotech sector by supporting their non-core business. The strategy is based on a five-pillar approach: Business Strategy – Corporate Finance – Subsidies & Funding – Expertise & Networking – Completion & Governance.

You are an entrepreneur active in the health field looking for helpYou are an investor looking for support before or after an investment? Do not hesitate to contact us.